Lec 15 - Drug Dev Flashcards

1
Q

what is the dif between pharma and biotech

A

pharma is drugs from chemicals, biotech is tech based on bio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe the cycle from drug discovery to evolution of product. where does preclin studied, clinical trial review, submission review, monitoring and intervention, and product removal occur?

A

drug discovered
pre clin studises not in humans
then health canada approves studying in humans
clinical trials
clinical trial review
drug submission
submission review
licence
post market
knowledge aquisition
monitoring, needed interventions
revaluation
removal if needed
evolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the four phases of drug discovery? what happens in each?

A

target discovery: finding the targets for the drug
target validation: eliminating the wrong targets
lead generation and refinement: generating molecules
preclinical development: eliminating and dvancing molecules

this all happens in drug discovery! way before any trials and testing!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

t/f: all of the drugs make it to the market. why or why not?

A

false: lots of the drugs get eliminated along the way bc they done pass tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the drug dev funnel

A

lots during basic research, funneling out from 100 000-25000 to 10-20 in preclin/animal studies
then 5-10 in phase 1
2-5 in phase 2
2 in phase 3
1 in phase 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

typically how long does the drug dev process take? describe what happens at each time point

A

in total up to 15 years.
3-6 years spend on drug discovery and preclin
6-7 years spent on clinical studies
0.5-2 years spent on regulatory review
afterwards is post marketing review

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

contrast phase 1, 2, 3, clinical studies

A
  1. looking mainly at pk/pd, dosing range, safety
  2. looking at efficacy, dose, safety
  3. looking at safety, efficiacy

more volunteers in each category as u go up the phases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why was the covid vaccine timeline so accelerated?

A

many people working on it at once, review process happened a lot faster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what happens after you determine a vaccines efficacy?

A

approval, manufacturing, global vaccinations, and future directions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what does the second wave of vaccines do?

A

improves protection, deals with mutants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the drug dev process in the US?

A

drug discovery, preclinical studies + IND application
clinical development, fda review, post market monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does canada regulate food and therapeutics (ie: legislation? regulation?)`

A

food and drug act legislation, and food and drug regulation, and natural health product regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the role of the health products and food branch?

A

monitors safety and efficacy of health product, food, and vet drugs
nutrition and food policies
public health response wrt food and nutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the pharmaceutical drugs directorate> what do they do?

A

they review safety and efficacy of prescription drugs, clinical trial applications,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does the patent act state?

A

manufacturers of a brand name drug have 17 years of patent protection from patent issuing or 20 years from patent filing date

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when should preclinical testing happen? what do you examine during this phase?

A

before clinical trial application for humans. look at structure activity relationship, animal studies, pk, adrs, pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

when does the clinical trial application occur>

A

after preclin testing and before clinical trials start

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

describe pathway from drug synthesis to new drug submission

A

synthestis, preclin testing, cta, clincal traisl (1, 2,3), new drug submission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what happens during phase 1 of clinical trials? what are u measuring? how many people?

A

drug is admin to health volunteers - small group – with controlled inclusion and exclusion.
measuring pk parameters, some safety by data safety monitoring board.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

contrast blinding and double blinding

A

blinding: patient doesnt know what theyre getting
double bl: patient and doc dont know what theyre getting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

when would you not use healthy volunteers for phase 1?

A

for wnticancer drugs, hiv drugs: you wouldnt want to test on health patients bc these are very potent drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the inclusion/exclusion criteria for phase 1?

A

want people that are going to stay for the whole study and who will have the least adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is the main goal of phase 1 clinical trial?

A

to figure out the pk principles of a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

when would you bypass phase 1 clinical trial?

A

when youre patient population is very sick and the drug is such that it would be harmful to a healthy patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

why shouldnt you give all patients the dose at the same time during a clinical trial?

A

wait some time so you can see if the drug is affecting someone first (2006 paraxel for tgn1412 - leukemia and arthritis drug, 2016 trial in france)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what happens during a phase 2 clinical trial? what is the main goal?

A

actually testing the drugs in patients, seeing if the drug has therapeutic use, dosing adjustments, and examining safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what is proof of concept?

A

seeing if a drug does what it is supposed to from a therapeutic perspective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what happens during phase 3 clinical trial?

A

thousands of patients, comparisons to stand therapy, controlled inc.ex, expesnsive, can be sep while waiting for notice of compliance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

which phase of clinical trial does comparisons?

A

phase 3

30
Q

what is notice of compliance?

A

once the manufacturer receives it and the DIN, they can sell the product in canada: noc tells us that benefits outweigh risks and harms of product

31
Q

what i a new drug submission? what must it include?

A

contains scientific info about safety and efficacy and quality of product
preclinr esults
clin results
production details
packaging and labelling
ther value
conditions of use
adrs

32
Q

when would you have an abbreviated nds?

A

when youre a generic drug company

33
Q

what does an abbreviated nds need to have?

A

infor about packaging, production and labelling
safety and efficacy same as brand name
similar endpoints as brand name

34
Q

what is a supplemental nds? when would you use it?

A

when the manufacturer wants to make changes to a product already authorized

35
Q

what is the drug review process in canada? who does it?

A

all pharm drugs and devices reviewed and regulated by pharm drugs directorate, health products and food branch, and health canada. they look for safety, efficacy and quality

36
Q

what happens when a manufacturer receives notice of compliance

A

they can sell their product

37
Q

when would a NOC be assigned

A

when benefits of drugs outweigh the harms

38
Q

what is NON? what happens?

A

notice of non compliance: what a failed submission gets, and the manufacterer has to respond appropriately within a period of time

39
Q

what is a DIN?

A

drug identification number

40
Q

do natural products have a DIN?

A

nope. they are under the natural and non prescription health products branch and have a natural product number

41
Q

what is the PMPRB? what do they do?

A

patented medicine prices review board: regualtion of prices of patented medicines to make sure theyre not excessive (how much does it cost for wholesalers? hospitals? pharmacies?) but they cant control how mcuh wholesalers and retails sell for, and cant control generic drug pricing

42
Q

what happens during pricing review?

A

patentees have to file price and sales info about the drug twice a year for each form of their drug

43
Q

what is the special access program? when can it be used?

A

lets practitioners request access to drugs unavailable for sale in canada
can be used when patients have serious or life threatening conditions on compassionate and emergency basis when conventional therapies are unavilable

44
Q

what is the CADTH?

A

the canadian agency for drugs and tech in health

not for profit org that helps healthcare workers make infomred decsiions about best use of drugs and medical devices

45
Q

what happens during phase 4 clinical trials

A

post marketing surveillance and safety, read world issues with drug

46
Q

what are common reason that drugs are withdrawaled

A

lack of safety, efficacy, therapeutic interest, poor market performance

47
Q

how is study design related to trials

A

you can design trials in such a way that they are more efficient at the outset to figure out who the study works for

48
Q

contrast cohort vs case control designs

A

cohort looks forward in time: takes a sample of healthy patients, exposes them, sees if they have illness

case control: looks at population, sees if they have the illness, then sees if they were exposed (good for diseases that take a long time to develop)

49
Q

contrast the placebo and the nocebo effect

A

placebo: give someone something that looks like what should work and they start feeling better

nocebo: you think you have side effects just because you were exposed

50
Q

what are natural health products

A

naturally occuring substances made from plants animals, in tablets, creams, drops, etc

51
Q

what regulation oversees nhps

A

the natural and non presciption health products directorate (nnhpd) for regulatory approval

the marketed health products directorate for post market safety

the health products and food branch inspectorate to enforce regulations

52
Q

what is the nnhpd

A

the natural and non presciption health products directorate

53
Q

what is the mhpd

A

marketed health products directorate

54
Q

what is the hpmi

A

health products and food branch inspectorate

55
Q

what are the regulations for nhps

A

must be safe to use as overthe counter products for self medication

56
Q

what falls under nhps

A

vitamins and minerals, herbal remedies, homeopathy, traditional meds, probiotics, emino acids, essential fas

57
Q

what does not count as an nhp

A

biologics, injectables, tobacco, marijuana

58
Q

what is the npn

A

the natural product number

59
Q

what are the characteristics s of authorized nhps

A

safe and effective, have an npn, have detailed label info, safe and effective when used according to instructions

60
Q

how do you know if nhps are safe

A

clinical trial data evidence, published studies, trad sources

61
Q

contrasting modern vs traditional health claims

A

modern: studies, animal, in vitro, textbooks, peer reviewed, regulatory authority reports

traditional health claimes: based on knowledge and practice based on theory belief and culture , but has to be shown to be used for two generations

62
Q

what is the objective of nhp regulations

A

providing assurance that products are safe effacacious and high quality

63
Q

what is homeopathy

A

super dilute products, based that a disease can be cured by a product that results in similar symptoms

64
Q

how are homeopathic products reviewed

A

make sure that what they aim to do is referenced somewhere, generally approved on the basis that the products would be low risk

65
Q

what are nosodes

A

homeopathic treatment derived from an element of disease or diseased tissue

66
Q

how are nosodes regulated? what happens to children given nosodes?

A

should not be used as a vaccine alternative. regulated by health canada. children are at higher risk of getting fatal childhood illnesses.

67
Q

how do homeopathic products have to be labelled

A

“this claim is based on traditional homeopathic references and not modern scientific data”

68
Q

how can a drug be eligible to have DIN-HM

A

(homeo medicine number) : can only be sold if they meet minimum homeo potency as established by nnhpd

69
Q

what do product liscencing submissions need to have? site liscening?

A

this isnt required for products compunded on an individual basis

product: they need to have ingredients, source, potency, non med ingredients, recc use

site: distribution record, procedure for product recall, handling strage and delivery, meet gmp

70
Q

what is good manufacturing process

A

proper stands for testing, manufacture, storage, handling, and distribution of nhp

ie product specs, premises, equipment, personnel, sanitation, quality assurance, stability, records..

71
Q

what are labelling requirements for nhps

A

product name, liscence number, quanity, ingredients, recc use, route of admin, cautionary statements, storage

72
Q

what are potential risks for nhps

A

manufacturing problems, unproven claimes, not enough info, interactions with prescription drugs, unwanted side effects